196 related articles for article (PubMed ID: 1494946)
1. Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine.
Snyder GL; Girault JA; Chen JY; Czernik AJ; Kebabian JW; Nathanson JA; Greengard P
J Neurosci; 1992 Aug; 12(8):3071-83. PubMed ID: 1494946
[TBL] [Abstract][Full Text] [Related]
2. Na+,K(+)-ATPase phosphorylation in the choroid plexus: synergistic regulation by serotonin/protein kinase C and isoproterenol/cAMP-PK/PP-1 pathways.
Fisone G; Snyder GL; Aperia A; Greengard P
Mol Med; 1998 Apr; 4(4):258-65. PubMed ID: 9606178
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo.
Desdouits F; Cohen D; Nairn AC; Greengard P; Girault JA
J Biol Chem; 1995 Apr; 270(15):8772-8. PubMed ID: 7721783
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.
Girault JA; Hemmings HC; Williams KR; Nairn AC; Greengard P
J Biol Chem; 1989 Dec; 264(36):21748-59. PubMed ID: 2557337
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra.
Tsou K; Snyder GL; Greengard P
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3462-5. PubMed ID: 8386374
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide analogs of DARPP-32 (Mr 32,000 dopamine- and cAMP-regulated phosphoprotein), an inhibitor of protein phosphatase-1. Phosphorylation, dephosphorylation, and inhibitory activity.
Hemmings HC; Nairn AC; Elliott JI; Greengard P
J Biol Chem; 1990 Nov; 265(33):20369-76. PubMed ID: 2173704
[TBL] [Abstract][Full Text] [Related]
7. Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin.
Desdouits F; Siciliano JC; Greengard P; Girault JA
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2682-5. PubMed ID: 7708705
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla.
Higuchi E; Nishi A; Higashi H; Ito Y; Kato H
Eur J Pharmacol; 2000 Nov; 408(2):107-16. PubMed ID: 11080516
[TBL] [Abstract][Full Text] [Related]
9. DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons.
Nairn AC; Hemmings HC; Walaas SI; Greengard P
J Neurochem; 1988 Jan; 50(1):257-62. PubMed ID: 3335843
[TBL] [Abstract][Full Text] [Related]
10. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution.
Hemmings HC; Greengard P
J Neurosci; 1986 May; 6(5):1469-81. PubMed ID: 3711991
[TBL] [Abstract][Full Text] [Related]
11. D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin.
Mayerhofer A; Fritz S; Grünert R; Sanders SL; Duffy DM; Ojeda SR; Stouffer RL
J Clin Endocrinol Metab; 2000 Dec; 85(12):4750-7. PubMed ID: 11134138
[TBL] [Abstract][Full Text] [Related]
12. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.
Halpain S; Girault JA; Greengard P
Nature; 1990 Jan; 343(6256):369-72. PubMed ID: 2153935
[TBL] [Abstract][Full Text] [Related]
13. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated neuronal phosphoprotein. II. Comparison of the kinetics of phosphorylation of DARPP-32 and phosphatase inhibitor 1.
Hemmings HC; Nairn AC; Greengard P
J Biol Chem; 1984 Dec; 259(23):14491-7. PubMed ID: 6501303
[TBL] [Abstract][Full Text] [Related]
14. Regulation of DARPP-32 dephosphorylation at PKA- and Cdk5-sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase-2A.
Nishi A; Bibb JA; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
J Neurochem; 2002 May; 81(4):832-41. PubMed ID: 12065642
[TBL] [Abstract][Full Text] [Related]
15. Distribution of protein phosphatase inhibitor-1 in brain and peripheral tissues of various species: comparison with DARPP-32.
Hemmings HC; Girault JA; Nairn AC; Bertuzzi G; Greengard P
J Neurochem; 1992 Sep; 59(3):1053-61. PubMed ID: 1353788
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
Svenningsson P; Lindskog M; Ledent C; Parmentier M; Greengard P; Fredholm BB; Fisone G
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1856-60. PubMed ID: 10677546
[TBL] [Abstract][Full Text] [Related]
17. Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.
Desdouits F; Siciliano JC; Nairn AC; Greengard P; Girault JA
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):211-6. PubMed ID: 9461512
[TBL] [Abstract][Full Text] [Related]
18. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G
Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376
[TBL] [Abstract][Full Text] [Related]
19. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
Hemmings HC; Greengard P; Tung HY; Cohen P
Nature; 1984 Aug 9-15; 310(5977):503-5. PubMed ID: 6087160
[TBL] [Abstract][Full Text] [Related]
20. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.
Brown AM; Deutch AY; Colbran RJ
Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
